![](/img/cover-not-exists.png)
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
J. F. de Groot, M. R. Gilbert, K. Aldape, K. R. Hess, T. A. Hanna, S. Ictech, M. D. Groves, C. Conrad, H. Colman, V. K. Puduvalli, V. Levin, W. K. A. YungVolume:
90
Language:
english
Pages:
9
DOI:
10.1007/s11060-008-9637-y
Date:
October, 2008
File:
PDF, 255 KB
english, 2008